FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...